SCHEMBL4311410

SCHEMBL4311410

NC(=O)Oc1ccc(O)c(F)c1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
KIF11 P52732 1/20 0.43
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
HSD17B10 Q99714 1/20 0.41
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
ESR1 P03372 3/20 0.38
ESR2 Q92731 3/20 0.38
SNCA P37840 1/20 0.38
MIF P14174 1/20 0.37
NR1H4 Q96RI1 1/20 0.36
SOS1 Q07889 1/20 0.35
KDM1A O60341 1/20 0.35
PARP10 Q53GL7 2/20 0.35
PARP15 Q460N3 1/20 0.35
HSD17B1 P14061 1/20 0.34
HSD17B2 P37059 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29250971 0.85 MEN1 (0.53) MEN1KMT2AKIF11POLBMAPT
SCHEMBL30063441 0.84 MEN1 (0.57) MEN1KMT2AKIF11SOS1PARP10
SCHEMBL5265818 0.84 MEN1 (0.57) MEN1KMT2AKIF11SOS1PARP10
SCHEMBL5697552 0.82 MEN1 (0.59) MEN1KMT2AKIF11KDM4EHSD17B10
SCHEMBL27511537 0.81 MEN1 (0.53) MEN1KMT2AKIF11ESR1ESR2
SCHEMBL377567 0.81 CYP3A4 (0.52) MEN1KMT2AKDM4ELMNAPOLB
SCHEMBL4789760 0.80 MAPT (0.38) KMT2AKDM4ELMNAHSD17B10POLB
SCHEMBL440172 0.79 MEN1 (0.52) MEN1KMT2AKIF11MAPTSOS1
SCHEMBL5260935 0.79 MEN1 (0.52) MEN1KMT2AKIF11
SCHEMBL17801666 0.79 KMT2A (0.52) MEN1KMT2AKIF11ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116283916-B Compound with Axl and c-Met kinase inhibition activity and preparation and application thereof 中国科学院上海药物研究所 2024-06-11 CN disclosed
CN-116283916-A Compound with Axl and c-Met kinase inhibition activity and preparation and application thereof 中国科学院上海药物研究所 2023-06-23 CN disclosed
WO-2022270980-A1 NOVEL UREA DERIVATIVE COMPOUND AS RON INHIBITOR 주식회사 엘지화학 2022-12-29 WO disclosed
WO-2022270979-A1 NOVEL UREA DERIVATIVE COMPOUND AS RON INHIBITOR 주식회사 엘지화학 2022-12-29 WO disclosed
CN-115279760-A Novel HPK1 inhibitor and preparation method and application thereof 轶诺(浙江)药业有限公司 2022-11-01 CN disclosed
CN-112457295-B Compound with Axl and c-Met kinase inhibitory activity and preparation and application thereof 中国科学院上海药物研究所 2022-07-26 CN disclosed
EP-4029862-A1 COMPOUND HAVING AXL AND C-MET KINASE INHIBITORY ACTIVITY, PREPARATION THEREOF AND APPLICATION THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2022-07-20 EP disclosed
WO-2021043217-A1 COMPOUND HAVING AXL AND C-MET KINASE INHIBITORY ACTIVITY, PREPARATION THEREOF AND APPLICATION THEREOF 中国科学院上海药物研究所 2021-03-11 WO disclosed
CN-112457295-A Compound with Axl and c-Met kinase inhibitory activity and preparation and application thereof 中国科学院上海药物研究所 2021-03-09 CN disclosed
WO-2009136663-A1 FUSED HETEROCYCLIC DERIVATIVES AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-12 WO disclosed